Patient #. Sex; age, years | Elevated biomarker concentrationsa | Clinical HF | New arrhythmia | Clinical outcome | Chemotherapy cycles received, n | Cancer outcomes | |
---|---|---|---|---|---|---|---|
Troponin | BNP | ||||||
Without dexrazoxane | |||||||
 1. M; 87 | Not available | Not available | Yes | NSVT | Cardiogenic shock, HF, death | 6 | Died |
 2. M; 66 | Not available | Not available | Yes | No | Cardiogenic shock, HF, death | 3 | Died |
 3. M; 65 | Not available | Not available | Yes | No | Required ICD | 2 | Alive at 12 months after Allo SCT |
With dexrazoxane | |||||||
 4. F; 67 | No | No | No | NSVT | Alive at 30 months | 6 | Complete remission |
 5. F; 75 | No | No | No | No | Alive at 18 months, Needed BiV ICD implantation | 6 | Complete remission |
 6. F 70 | No | No | No | No | Alive at 12 months | 6 | Partial response |
 7. M; 73 | No | No | No | No | Alive at 15 months | 6 | Complete remission |
 8. F; 68 | No | No | No | NSVT | Alive at 12 months | 6 | Complete response |